Severe hypomagnesaemia with tetany following ESHAP protocol
BACKGROUND: One patient with B-cell Non-Hodgkin's Lymphoma developed severe hypomagnesaemia and tetany 15 days after the first course of treatment with ESHAP protocol. This prompted a careful look at the incidence and severity of hypomagnesaemia during treatment with this combination chemotherapy. M...
-д хадгалсан:
| -д хэвлэсэн: | BMC Blood Disord |
|---|---|
| Үндсэн зохиолч: | |
| Формат: | Artigo |
| Хэл сонгох: | Inglês |
| Хэвлэсэн: |
BMC
2002
|
| Нөхцлүүд: | |
| Онлайн хандалт: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC64621/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11801194/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/1471-2326-2-1 |
| Шошгууд: |
Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!
|